1st Circ. Grills Attys On Nexium Pay-For-Delay Class Cert.
A First Circuit panel voiced skepticism Thursday of AstraZeneca PLC's claim that a pay-for-delay case couldn't be certified as a class action if the class included any uninjured buyers, but the...To view the full article, register now.
Already a subscriber? Click here to view full article